Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-18

Clinical Trial Update: Dolutegravir and Darunavir Evaluation in Adults Failing Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dolutegravir and darunavir in adults failing therapy for HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darunavir (darunavir)
  • Dolutegravir (dolutegravir)

Snippet

Sponsor: Kirby Institute | Conditions: HIV Infections | Phase 4 | Status: UNKNOWN